Oct. 25 at 9:53 AM
$KURA Kura Oncology CEO Troy Edward Wilson bought shares in September 2025, acquiring 50,000 shares for approximately
$410,145. He also sold 36,615 shares in late September 2025 for about
$327,418 to cover taxes, according to MarketBeat and Investing.com.
September 2025 Purchase: Wilson bought 50,000 shares at a weighted average price of about
$8.20 per share.
September 2025 Sale: He sold 36,615 shares for approximately
$327,418.
Reason for Sale: The sale was to cover taxes on performance-based restricted stock units that had vested.